Stock listing

Polypeptide Group Ag

Selected listing: 8H0 · BX · CHF · CH

Polypeptide Group Ag (BX Swiss: 8H0), Health Technology. Latest release Apr 8, 2026: PolyPeptide announces results of the annual General Meeting 2026.

8H0:BXCHFCHUpdated October 2, 2026

Ticker: BX Swiss: 8H0
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: BX Swiss
Currency: CHF

About Polypeptide Group Ag

The company specializes in the development and manufacturing of peptide-based therapeutics. With a strong presence in the pharmaceutical industry, Polypeptide Group AG focuses on delivering innovative solutions to meet the needs of its clients.

Latest news from Polypeptide Group Ag

PolyPeptide announces results of the annual General Meeting 2026

April 8, 2026

PolyPeptide strengthens financing structure through expansion of existing credit facility

March 19, 2026

PolyPeptide publishes invitation to the annual General Meeting 2026

March 17, 2026

PolyPeptide delivers strong revenue growth and marked improvement in profitability

March 12, 2026

PolyPeptide successfully closes financial year 2025 with strong revenue growth and marked improvement in profitability

January 19, 2026

All Polypeptide Group Ag news →

Research Polypeptide Group Ag

Polypeptide Group Ag company profile

View the public company page for Polypeptide Group Ag on 6ix.

Polypeptide Group Ag news

Read company news and market updates connected to Polypeptide Group Ag.

Polypeptide Group Ag investor events

Find investor webinars, events, and replay context for Polypeptide Group Ag.